Monitor the company's next quarterly earnings for the actual interest expense impact and any guidance on leverage ratios post-refinancing. The higher coupon (9.5%) and near-200bps rate increase suggest meaningful earnings headwind.
Price Chart
Executive Summary
Integra LifeSciences priced $450 million of 9.500% senior secured notes due 2033 as part of a broader debt refinancing. The company expects its effective interest rate to increase near the high end of the previously communicated 100-200 basis point range, signaling higher interest costs going forward.
Key Facts
- Priced $450 million aggregate principal amount of 9.500% senior secured notes due 2033
- Notes expected to close on or about October 19, 2026
- Proceeds, together with new credit facility borrowings, will refinance existing credit facilities and pay fees/expenses
- Effective interest rate expected near high end of previously guided 100-200 bps increase range
- Notes are unregistered, offered via Rule 144A and Regulation S
Financial Impact
$450 million of new 9.500% senior secured notes; effective interest rate increase near 200 bps
Risk Factors
- Higher interest expense reduces net income and free cash flow
- Refinancing may extend maturity but at a significantly higher cost
- 9.5% coupon indicates below-investment-grade credit profile
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-419228 |
| Document: d151933dex991.htm | 0001193125-26-419228 |
| Document: 0001193125-26-419228-index-headers.html | 0001193125-26-419228 |
| Document: 0001193125-26-419228-index.html | 0001193125-26-419228 |
| Document: 0001193125-26-419228.txt | 0001193125-26-419228 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 21, 2026 5d ago | 8-K | $11.84 | awaiting T+5 | — | $12.13 (−2.41%) |
Oct 19, 2026 6d ago | 8-K | $13.33 | awaiting T+5 | — | $12.13 (−9.04%) |
Oct 14, 2026 12d ago | Court Ruling | $13.53 $12.33 | ▼ −8.91% | ▼ −7.89% | $12.13 (−10.38%) |
Oct 13, 2026 12d ago | 3 | $13.18 $11.84 | ▼ −10.13% | ▼ −10.59% | $12.13 (−7.97%) |
Oct 9, 2026 16d ago | 8-K | $13.98 $13.45 | ▲ +3.79% | ▲ +2.30% | $12.13 (+13.27%) |
Oct 6, 2026 20d ago | Press Release | $13.32 | awaiting T+5 | — | $12.13 (−8.97%) |
Oct 2, 2026 24d ago | 8-K | $12.68 $13.44 | ▼ −5.99% | ▼ −4.83% | $12.13 (+4.38%) |
Oct 2, 2026 24d ago | Press Release | $12.68 $13.44 | ▼ −5.99% | ▼ −4.83% | $12.13 (+4.38%) |
Sep 8, 2026 6w ago | 8-K | $16.26 $15.71 | ▼ −3.38% | ▼ −2.72% | $12.13 (−25.43%) |
May 8, 2026 24w ago | 8-K | $13.97 $14.11 | ▲ +1.00% | ▲ +1.09% | $12.13 (−13.21%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers